Hydrocodone is a Schedule II pain reliever synthesized from opium and sold under brand names such as Vicodin and Lortab; its “safe” reputation among doctors has contributed to its being easily available, despite its Schedule II classification. Hydrocodone addiction treatment enrollment has steadily increased across all social groups in recent years, even though it is generally viewed as a white-collar drug. The common availability, combined with effects that are similar to, but not as strong as morphine, make hydrocodone deceptively addictive and harmful. Respiration problems, confusion, fatigue, and dizziness are frequently results of addiction, and if pills are coupled with alcohol, coma and even death are potential consequences
The treatment for hydrocodone addiction, like many other drug treatment programs, consists of a medically assisted detoxification therapy program plus a long-term inpatient rehab stay, lasting anywhere from ninety days to a year, depending on the severity of the addiction. Detox uses a gradual lessening of dosage of hydrocodone to the patient over a moderate period of time in order to remove the drug from the patient’s system with minimal withdrawal effects. Once this procedure is completed, the patient is transferred to inpatient rehabilitation to receive ongoing medical treatment in addition to behavioral and community based therapies that help deal with the psychological side of the drug addiction.
Co-occurring disorders, such as depression or schizophrenia, are also treated during this time, in order to reduce the likelihood of the patient’s relapse once released. In order to better combat the chance of relapse, medical and family support networks are also organized for the patient to use following rehab.